CZ2003141A3 - Léčivo pro omezení výskytu a/nebo závažnosti nového vzplanutí nového chorobného procesu COPD - Google Patents

Léčivo pro omezení výskytu a/nebo závažnosti nového vzplanutí nového chorobného procesu COPD Download PDF

Info

Publication number
CZ2003141A3
CZ2003141A3 CZ2003141A CZ2003141A CZ2003141A3 CZ 2003141 A3 CZ2003141 A3 CZ 2003141A3 CZ 2003141 A CZ2003141 A CZ 2003141A CZ 2003141 A CZ2003141 A CZ 2003141A CZ 2003141 A3 CZ2003141 A3 CZ 2003141A3
Authority
CZ
Czechia
Prior art keywords
copd
pde4 inhibitor
ratio
pde4
rolipram
Prior art date
Application number
CZ2003141A
Other languages
Czech (cs)
English (en)
Inventor
Jeffrey D. Edelson
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of CZ2003141A3 publication Critical patent/CZ2003141A3/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CZ2003141A 2000-07-27 2001-07-26 Léčivo pro omezení výskytu a/nebo závažnosti nového vzplanutí nového chorobného procesu COPD CZ2003141A3 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22127500P 2000-07-27 2000-07-27

Publications (1)

Publication Number Publication Date
CZ2003141A3 true CZ2003141A3 (cs) 2004-07-14

Family

ID=22827112

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ2003141A CZ2003141A3 (cs) 2000-07-27 2001-07-26 Léčivo pro omezení výskytu a/nebo závažnosti nového vzplanutí nového chorobného procesu COPD

Country Status (16)

Country Link
EP (1) EP1320361A4 (zh)
JP (1) JP2004505039A (zh)
KR (1) KR20030019620A (zh)
CN (1) CN1444476A (zh)
AR (1) AR029984A1 (zh)
AU (2) AU7902301A (zh)
BR (1) BR0112682A (zh)
CA (1) CA2417336A1 (zh)
CZ (1) CZ2003141A3 (zh)
HU (1) HUP0300685A3 (zh)
IL (1) IL153919A0 (zh)
MX (1) MXPA03000714A (zh)
NO (1) NO20030332D0 (zh)
PL (1) PL365612A1 (zh)
WO (1) WO2002009689A1 (zh)
ZA (1) ZA200300476B (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
US7776315B2 (en) 2000-10-31 2010-08-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and additional active ingredients
DE10110772A1 (de) * 2001-03-07 2002-09-12 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und PDE-IV-Inhibitoren
GB0118373D0 (en) * 2001-07-27 2001-09-19 Glaxo Group Ltd Novel therapeutic method
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
DE10230769A1 (de) * 2002-07-09 2004-01-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und PDE-IV-Inhibitoren
ME00524B (me) 2003-03-10 2011-10-10 Astrazeneca Ab Novi postupak za dobijanje roflumilasta
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
KR102087661B1 (ko) * 2018-07-27 2020-03-11 강원대학교산학협력단 Ｇｅｂｒ―７ｂ 화합물을 유효성분으로 포함하는 만성폐쇄성 폐질환의 예방 또는 치료용 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DZ3019A1 (fr) * 1999-03-01 2005-05-20 Smithkline Beecham Corp Utilisation d'un inhibiteur de pde4 dans la préparation d'un médicament contre la copd.
SE9902937D0 (sv) * 1999-08-18 1999-08-18 Astra Pharma Prod Pharmaceutical compositions
DZ3249A1 (fr) * 1999-10-29 2001-05-10 Smithkline Beecham Corp Procédé d'administration d'un inhibiteur phosphodiesterase 4

Also Published As

Publication number Publication date
KR20030019620A (ko) 2003-03-06
AR029984A1 (es) 2003-07-23
IL153919A0 (en) 2003-07-31
EP1320361A1 (en) 2003-06-25
AU7902301A (en) 2002-02-13
HUP0300685A3 (en) 2004-10-28
NO20030332L (no) 2003-01-22
AU2001279023B2 (en) 2005-11-10
HUP0300685A2 (hu) 2003-12-29
BR0112682A (pt) 2003-06-24
CA2417336A1 (en) 2002-02-07
NO20030332D0 (no) 2003-01-22
JP2004505039A (ja) 2004-02-19
MXPA03000714A (es) 2003-06-04
ZA200300476B (en) 2004-04-23
WO2002009689A1 (en) 2002-02-07
EP1320361A4 (en) 2006-04-05
CN1444476A (zh) 2003-09-24
PL365612A1 (en) 2005-01-10

Similar Documents

Publication Publication Date Title
US20060069155A1 (en) Method for reducing exacerbations associated with COPD
Sung et al. Randomized, controlled trial of inhaled budesonide as an adjunct to oral prednisone in acute asthma
JP2017165740A (ja) ラキニモドを使用したループス腎炎の治療
EP2799071B1 (en) Levocetirizine and montelukast for the treatment of influenza and common cold
Skoner Balancing safety and efficacy in pediatric asthma management
US20110218203A1 (en) Treatment of rheumatoid arthritis with a combination of laquinimod and methotrexate
JP2005511749A (ja) Ｂ型肝炎ウィルス感染症を治療するためのホスホネートヌクレオチド類似体の使用
KR20070032619A (ko) 폐동맥 고혈압의 치료를 위한 일로프로스트의 복합 치료제
RU2384339C2 (ru) Применение симетикона для предрасположенных к запорам пациентов
CZ2003141A3 (cs) Léčivo pro omezení výskytu a/nebo závažnosti nového vzplanutí nového chorobného procesu COPD
JP2008517988A (ja) 不眠症の治療において有用な新規な製剤処方
JP2021500377A (ja) 遅延放出デフェリプロン錠剤及びその使用法
AU2001279023A1 (en) Method for reducing exacerbations associated with COPD
EP3544608A1 (en) Methods of enhancing immune response with everolimus, dactolisib or both
CZ20021443A3 (cs) Způsob podávání inhibitoru fosfodiesterázy 4
TWI242431B (en) Pharmaceutical compositions for treating pulmonary diseases
KR20230018481A (ko) 질병의 치료를 위한 2-(다이에틸아미노)에틸 2-(4-아이소부틸페닐)프로피오네이트의 국소 투여
US20060035877A1 (en) Method and compositions for treating pulmonary diseases
JP2007515418A (ja) 塩基性医薬活性物質の発泡調製物
Owen et al. A phase 1 study to evaluate the safety, tolerability, and pharmacokinetics of inhaled GDC-0214, a JAK1 inhibitor, as single-and multiple-ascending doses in healthy volunteers
US20230172895A1 (en) Methods of treating or preventing organophosphorus poisoning
RU106840U1 (ru) Диспергируемая в воде лекарственная таблетка противотуберкулезного действия
WO2023004427A1 (en) Treatment of severe and uncomplicated malaria
US20220117916A1 (en) Combination Products to Mitigate the Risk of Non-Benzodiazepine Benzodiazepine Agonist Adverse Reaction and Overdose
WO2007028413A1 (en) Pharmaceutical composition suitable for the treatment of malaria within one day